0.59 (4.27%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Weak
Earnings
Very Strong
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Janux Therapeutics, Inc.
Telephone
1.858.751.4493
Address
Suite 200, 10955 Vista Sorrento Parkway, San Diego, CA 92130
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 12.12 - 35.34
Trade Value (12mth)
US$5,846,337.00
1 week
-0.58%
1 month
-10.67%
YTD
1.17%
1 year
-44.25%
All time high
71.71
EPS 3 yr Growth
20.60%
EBITDA Margin
NaN%
Operating Cashflow
-$82m
Free Cash Flow Return
-8.10%
ROIC
-11.20%
Interest Coverage
0.00
Quick Ratio
39.00
Shares Outstanding (Fully Diluted)
63m
HALO Sector
Healthcare
Next Company Report Date
05-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 08 May 26 | |
| 08 May 26 | |
| 08 May 26 | |
| 08 May 26 | |
| 08 May 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -1.32 | -1.28 | -1.83 | | | | ||
EPS (Fully Diluted) | $ | | | | | -1.32 | -1.28 | -1.83 | | | | ||
Growth | % | | | | | 12.9 | 3.1 | -42.8 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
